Citation Impact
Citing Papers
Direct and Catalytic C ‐Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside**
2021 StandoutNobel
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
[d4U]-Spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase
2010
Chlorogenic acid (CGA): A pharmacological review and call for further research
2017 Standout
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Polyphenols: A Diverse Class of Multi-Target Anti-HIV-1 Agents
2013
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Enantioselective Enzymes by Computational Design and In Silico Screening
2015 StandoutNobel
The use of spirocyclic scaffolds in drug discovery
2014 Standout
N-Myristoylglutamic acid derivative of 3′-fluoro-3′-deoxythymidine as an organogel
2012
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Synthesis and in vitro anti-HIV activity of N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives using MTT method
2011
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
Recent advances in Sonogashira reactions
2011 Standout
A short de novo synthesis of nucleoside analogs
2020 Science
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Progress In The Development Of Anti-Hepatitis C Virus Nucleoside And Nucleotide Prodrugs
2012
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Nucleotide Prodrugs of 2′-Deoxy-2′-spirooxetane Ribonucleosides as Novel Inhibitors of the HCV NS5B Polymerase
2013
Experimental and Clinical Pharmacology ofAndrographis paniculataand Its Major Bioactive Phytoconstituent Andrographolide
2013 Standout
Bioenergetics and translational metabolism: implications for genetics, physiology and precision medicine
2019
Site-Selective Functionalization of Hydroxyl Groups in Carbohydrate Derivatives
2018
Functional π-Gelators and Their Applications
2014 Standout
Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates
2011
A substitution in the glutathione reductase lowers electron leakage and inflammation in modern humans
2022 StandoutNobel
Kinase Drug Discovery – What’s Next in the Field?
2012
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
2020
Structure-Based Design, Synthesis, and Structure−Activity Relationship Studies of HIV-1 Protease Inhibitors Incorporating Phenyloxazolidinones
2010
Enantioselective Enzymes by Computational Design and In Silico Screening
2015 StandoutNobel
Catalytic Asymmetric Protonation of Silyl Ketene Imines
2013 StandoutNobel
Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
2016
Characterization of γδ T Cells in Intestinal Mucosa From Patients With Early-Onset or Long-Standing Inflammatory Bowel Disease and Their Correlation With Clinical Status
2019
Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design
2013 StandoutNobel
Hypericum hircinumL. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities
2013
Works of Youcef Mehellou being referenced
Design, synthesis, and anti-HIV activity of 2′,3′-didehydro-2′,3′-dideoxyuridine (d4U), 2′,3′-dideoxyuridine (ddU) phosphoramidate ‘ProTide’ derivatives
2007
Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells
2009
An investigation into the anti-HIV activity of 2′,3′-didehydro-2′,3′-dideoxyuridine (d4U) and 2′,3′-dideoxyuridine (ddU) phosphoramidate ‘ProTide’ derivatives
2009
Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism
2010
MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases
2011
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
2009
The ProTide Prodrug Technology: From the Concept to the Clinic
2017
Synthesis and Biological Evaluation of (E)-4-Hydroxy-3-methylbut-2-enyl Phosphate (HMBP) Aryloxy Triester Phosphoramidate Prodrugs as Activators of Vγ9/Vδ2 T-Cell Immune Responses
2018
The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1
2017
Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization
2017